Does the Developmental Status of Vα14i NKT Cells Play a Role in Disease?

REFERENCES

• M. Kronenberg, Toward an understanding of NKT cell biology: Progress and paradoxes, Annu. Rev. Immunol., 23: 877–900, 2005.
   PubMed Web of Science ®Google Scholar
• D.I. Godfrey, H.R. MacDonald, M. Kronenberg, M.J. Smyth, and L. Van Kaer, NKT cells: What's in a name? Nat. Rev. Immunol., 4: 231–237, 2004.
   PubMed Web of Science ®Google Scholar
• O. Lantz and A. Bendelac, An invariant T cell receptor chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4−8− T cells in mice and humans, J. Exp. Med., 180: 1097–1106, 1994.
   PubMed Web of Science ®Google Scholar
• P. Dellabona, E. Padovan, G. Casorati, M. Brockhaus, and A. Lanzavecchia, An invariant V24-JαQ/Vβ11 T cell receptor is expressed in all individuals by clonally expanded CD4−8− T cells, J. Exp. Med., 180: 1171–1176, 1994.
   PubMed Web of Science ®Google Scholar
• A. Bendelac, Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes, J. Exp. Med., 182: 2091–2096, 1995.
   PubMed Web of Science ®Google Scholar
• K. Benlagha, A. Weiss, A. Beavis, L. Teyton, and A. Bendelac, In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers, J. Exp. Med., 191: 1895–1903, 2000.
   PubMed Web of Science ®Google Scholar
• J.L. Matsuda, O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. Wang, Y. Koezuka, and M. Kronenberg, Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers, J. Exp. Med., 192: 741–754, 2000.
   PubMed Web of Science ®Google Scholar
• M. Kronenberg and L. Gapin, The unconventional lifestyle of NKT cells, Nat. Rev. Immunol., 2: 557–568, 2002.
   PubMed Web of Science ®Google Scholar
• M. Brigl and M.B. Brenner, CD1: Antigen presentation and T cell function, Annu. Rev. Immunol., 22: 817–890, 2004.
   PubMed Web of Science ®Google Scholar
• D.I. Godfrey and M. Kronenberg, Going both ways: Immune regulation via CD1d-dependent NKT cells, J. Clin. Invest., 114: 1379–1388, 2004.
   PubMed Web of Science ®Google Scholar
• K.O. Yu, J.S. Im, A. Molano, Y. Dutronc, P.A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, Y.T. Chang, G.S. Besra, and S.A. Porcelli, Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of α-galactosylceramides, Proc. Natl. Acad. Sci. U.S.A., 102: 3383–3388, 2005.
   PubMed Web of Science ®Google Scholar
• J.L. Matsuda, L. Gapin, J.L. Baron, S. Sidobre, D.B. Stetson, M. Mohrs, R.M. Locksley, and M. Kronenberg, Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vivo, Proc. Natl. Acad. Sci. U.S.A., 100: 8395–8400, 2003.
   PubMed Web of Science ®Google Scholar
• M.J. Smyth and D.I. Godfrey, NKT cells and tumor immunity—a double-edged sword, Nat. Immunol., 1: 459–460, 2000.
   PubMed Web of Science ®Google Scholar
• Y. Ikarashi, A. Iizuka, Y. Koshidaka, Y. Heike, Y. Takaue, M. Yoshida, M. Kronenberg, and H. Wakasugi, Phenotypical and functional alterations during the expansion phase of invariant Vα14 natural killer T (Vα14i NKT) cells in mice primed with α-galactosylceramide, Immunology, 116: 30–37, 2005.
   PubMedGoogle Scholar
• D.B. Stetson, M. Mohrs, R.L. Reinhardt, K. Mohrs, J.L. Baron, Z.-E. Wang, L. Gapin, M. Kronenberg, and R.M. Locksley, Constitutive cytokine mRNAs mark natural killer (NK) and NKT cells poised for rapid effector function, J. Exp. Med., 198: 1069–1076, 2003.
   PubMed Web of Science ®Google Scholar
• S. Tanaka, J. Tsukada, W. Suzuki, K. Hayashi, K. Tanigaki, M. Tsuji, H. Inoue, T. Honjo, and M. Kubo, The interleukin-4 enhancer CNS-2 is regulated by notch signals and controls initial expression in NKT cells and memory-type CD4 T cells, Immunity, 24: 689–701, 2006.
   PubMed Web of Science ®Google Scholar
• J.L. Matsuda, Q. Zhang, R. Ndonye, S.K. Richardson, A.R. Howell, and L. Gapin, T-bet concomitantly controls migration, survival and effector functions during the development of Vα14i NKT cells, Blood, 107: 2797–2805, 2006.
   PubMed Web of Science ®Google Scholar
• J.L. Matsuda, L. Gapin, S. Sidobre, W.C. Kieper, J.T. Tan, R. Ceredig, C.D. Surh, and M. Kronenberg, Homeostasis of Vα14i NKT cells, Nat. Immunol., 3: 966–974, 2002.
   Web of Science ®Google Scholar
• M. Taniguchi and T. Nakayama, Recognition and function of Vα14 NKT cells, Semin. Immunol., 12: 543–550, 2000.
   PubMed Web of Science ®Google Scholar
• Y. Makino, N. Yamagata, T. Sasho, Y. Adachi, R. Kanno, H. Koseki, M. Kanno, and M. Taniguchi, Extrathymic development of Vα14+ T cells, J. Exp. Med., 177: 1399–1408, 1993.
   Google Scholar
• D.G. Pellicci, K.J.L. Hammond, A.P. Uldrich, A. Baxter, M.J. Smyth, and D.I. Godfrey, NKT cells develop through a thymus-dependent NK1.1−CD4+ CD1d-dependent precursor stage, J. Exp. Med., 195: 835–844, 2002.
   PubMed Web of Science ®Google Scholar
• F. Tilloy, J.P. Di Santo, A. Bendelac, and O. Lantz, Thymic dependence of invariant Vα14+ natural killer-T cell development, Eur. J. Immunol., 29: 3313–3318, 1999.
   Google Scholar
• A. Bendelac, M.N. Rivera, S.H. Park, and J.H. Roark, Mouse CD1-specific NK1 T cells: Development, specificity, and function, Annu. Rev. Immunol., 15: 535–562, 1997.
   PubMed Web of Science ®Google Scholar
• M. Shimamura, T. Ohteki, U. Beutner, and H.R. MacDonald, Lack of directed Vα14-Jα281 rearrangements in NK1+ T cells, Eur. J. Immunol., 27: 1576–1579, 1997.
   Google Scholar
• N. Yannoutsos, P. Wilson, W. Yu, H.T. Chen, A. Nussenzweig, H. Petrie, and M.C. Nussenzweig, The role of recombination activating gene (RAG) reinduction in thymocyte development in vivo, J. Exp. Med., 194: 471–480, 2001.
   Google Scholar
• S.D. Thompson, J. Pelkonen, and J.L. Hurwitz, First T cell receptor α gene rearrangements during T cell ontogeny skew to the 5′ region of the J locus, J. Immunol., 145: 2347–2352, 1990.
   PubMedGoogle Scholar
• N. Pasqual, M. Gallagher, C. Aude-Garcia, M. Loiodice, F. Thuderoz, J. Demongeot, R. Ceredig, P.N. Marche, and E. Jouvin-Marche, Quantitative and qualitative changes in V-J rearrangements during mouse thymocytes differentiation: Implication for a limited T cell receptor α chain repertoire, J. Exp. Med., 196: 1163–1173, 2002.
   PubMed Web of Science ®Google Scholar
• J. Guo, A. Hawwari, H. Li, Z. Sun, S.K. Mahanta, D.R. Littman, M.S. Krangel, and Y.W. He, Regulation of the TCR α repertoire by the survival window of CD4+CD8+ thymocytes, Nat. Immunol., 3: 469–476, 2002.
   PubMedGoogle Scholar
• L. Gapin, J.L. Matsuda, C.D. Surh, and M. Kronenberg, NKT cells derive from double-positive thymocytes that are positively selected by CD1d, Nat. Immunol., 2: 971–978, 2001.
   PubMed Web of Science ®Google Scholar
• K. Benlagha, T. Kyin, A. Beavis, L. Teyton, and A. Bendelac, A thymic precursor to the NKT cell lineage, Science, 296: 553–555, 2002.
   PubMed Web of Science ®Google Scholar
• Y. Takahama, A. Kosugi, and A. Singer, Phenotype, ontogeny, and repertoire of CD4−CD8− T cell receptor αβ+ thymocytes. Variable influence of self-antigens on T cell receptor Vβ usage, J. Immunol., 146: 1134–1141, 1991.
   Google Scholar
• T. Egawa, G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D.R. Littman, Genetic evidence supporting selection of the Vα14i NKT cell lineage from double-positive thymocyte precursors, Immunity, 22: 705–716, 2005.
   PubMed Web of Science ®Google Scholar
• J.S. Bezbradica, T. Hill, A.K. Stanic, L. Van Kaer, and S. Joyce, Commitment toward the natural T (iNKT) cell lineage occurs at the CD4+8+ stage of thymic ontogeny, Proc. Natl. Acad. Sci. U. S. A., 102: 5114–5119, 2005.
   PubMed Web of Science ®Google Scholar
• Z. Sun, D. Unutmaz, Y.R. Zou, M.J. Sunshine, A. Pierani, S. Brenner-Morton, R.E. Mebius, and D.R. Littman, Requirement for ROR γ in thymocyte survival and lymphoid organ development, Science, 288: 2369–2373, 2000.
   PubMed Web of Science ®Google Scholar
• T. Ohteki, A. Wilson, S. Verbeek, H.R. MacDonald, and H. Clevers, Selectively impaired development of intestinal T cell receptor γδ+ cells and liver CD4+ NK1+ T cell receptor αβ+ cells in T cell factor-1-deficient mice, Eur. J. Immunol., 26: 351–355, 1996.
   PubMed Web of Science ®Google Scholar
• F. Gounari, I. Aifantis, K. Khazaie, S. Hoeflinger, N. Harada, M.M. Taketo, and H. Von Boehmer, Somatic activation of βcatenin bypasses pre-TCR signaling and TCR selection in thymocyte development, Nat. Immunol., 2: 863–869, 2001.
   PubMedGoogle Scholar
• V. Ioannidis, F. Beermann, H. Clevers, and W. Held, The βcatenin–TCF-1 pathway ensures CD4+CD8+ thymocyte survival, Nat. Immunol., 2: 691–697, 2001.
   Google Scholar
• T. Dao, D. Guo, A. Ploss, A. Stolzer, C. Saylor, T.E. Boursalian, J.S. Im, and D.B. Sant'Angelo, Development of CD1d-restricted NKT cells in the mouse thymus, Eur. J. Immunol., 34: 3542–3552, 2004.
   Google Scholar
• T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, and M. Taniguchi, CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides, Science, 278: 1626–1629, 1997.
   PubMed Web of Science ®Google Scholar
• S.T. Smiley, M.H. Kaplan, and M.J. Grusby, Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells, Science, 275: 977–979, 1997.
   PubMedGoogle Scholar
• Y.H. Chen, N.M. Chiu, M. Mandal, N. Wang, and C.R. Wang, Impaired NK1+ T cell development and early IL-4 production in CD1- deficient mice, Immunity, 6: 459–467, 1997.
   PubMed Web of Science ®Google Scholar
• S.K. Mendiratta, W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer, CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4, Immunity, 6: 469–477, 1997.
   PubMed Web of Science ®Google Scholar
• Y.H. Chiu, S.H. Park, K. Benlagha, C. Forestier, J. Jayawardena-Wolf, P.B. Savage, L. Teyton, and A. Bendelac, Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d, Nat. Immunol., 3: 55–60, 2002.
   PubMed Web of Science ®Google Scholar
• D. Elewaut, A.P. Lawton, N.A. Nagarajan, E. Maverakis, A. Khurana, S. Honing, C.A. Benedict, E. Sercarz, O. Bakke, M. Kronenberg, and T.I. Prigozy, The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Vα14i NKT cells, J. Exp. Med., 198: 1133–1146, 2003.
   Google Scholar
• Y. Sagiv, K. Hudspeth, J. Mattner, N. Schrantz, R.K. Stern, D. Zhou, P.B. Savage, L. Teyton, and A. Bendelac, Cutting edge: Impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein, J. Immunol., 177: 26–30, 2006.
   Google Scholar
• D. Zhou, C. Cantu, 3rd, Y. Sagiv, N. Schrantz, A.B. Kulkarni, X. Qi, D.J. Mahuran, C.R. Morales, G.A. Grabowski, K. Benlagha, P. Savage, A. Bendelac, and L. Teyton, Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins, Science, 303: 523–527, 2004.
   Google Scholar
• A.K. Stanic, A.D. De Silva, J.J. Park, V. Sriram, S. Ichikawa, Y. Hirabyashi, K. Hayakawa, L. Van Kaer, R.R. Brutkiewicz, and S. Joyce, Defective presentation of the CD1d1-restricted natural Vα14Jα18 NKT lymphocyte antigen caused by β-D-glucosylceramide synthase deficiency, Proc. Natl. Acad. Sci. U. S. A., 100: 1849–1854, 2003.
   PubMedGoogle Scholar
• D. Zhou, J. Mattner, C. Cantu, 3rd, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, S. Teneberg, D. Wang, R.L. Proia, S.B. Levery, P.B. Savage, L. Teyton, and A. Bendelac, Lysosomal glycosphingolipid recognition by NKT cells, Science, 306: 1786–1789, 2004.
   PubMed Web of Science ®Google Scholar
• T.K. Starr, S.C. Jameson, and K.A. Hogquist, Positive and negative selection of T cells, Annu. Rev. Immunol., 21: 139–176, 2003.
   PubMed Web of Science ®Google Scholar
• A. Bendelac, M. Bonneville, and J.F. Kearney, Autoreactivity by design: Innate B and T lymphocytes, Nat. Rev. Immunol., 1: 177–186, 2001.
   PubMed Web of Science ®Google Scholar
• M.C. Coles and D.H. Raulet, NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+cells, J. Immunol., 164: 2412–2418, 2000.
   Google Scholar
• C. Forestier, S.H. Park, D. Wei, K. Benlagha, L. Teyton, and A. Bendelac, T cell development in mice expressing CD1d directed by a classical MHC class II promoter, J. Immunol., 171: 4096–4104, 2003.
   Google Scholar
• M.I. Zimmer, A. Colmone, K. Felio, H. Xu, A. Ma, and C.R. Wang, A cell-type specific CD1d expression program modulates invariant NKT cell development and function, J. Immunol., 176: 1421–1430, 2006.
   PubMed Web of Science ®Google Scholar
• D.G. Wei, H. Lee, S.H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and A. Bendelac, Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes, J. Exp. Med., 202: 239–248, 2005.
   PubMedGoogle Scholar
• J. Schumann, P. Pittoni, E. Tonti, H.R. Macdonald, P. Dellabona, and G. Casorati, Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of V 14i NKT cells, J. Immunol., 175: 7303–7310, 2005.
   PubMed Web of Science ®Google Scholar
• K. Nakagawa, K. Iwabuchi, K. Ogasawara, M. Ato, M. Kajiwara, H. Nishihori, C. Iwabuchi, H. Ishikura, R.A. Good, and K. Onoe, Generation of NK1.1+ T cell antigen receptor α/β+ thymocytes associated with intact thymic structure, Proc. Natl. Acad. Sci. U. S. A., 94: 2472–2477, 1997.
   Google Scholar
• V. Sivakumar, K.J. Hammond, N. Howells, K. Pfeffer, and F. Weih, Differential requirement for Rel/nuclear factor kB family members in natural killer T cell development, J. Exp. Med., 197: 1613–1621, 2003.
   Google Scholar
• K. Iizuka, D.D. Chaplin, Y. Wang, Q. Wu, L.E. Pegg, W.M. Yokoyama, and Y.X. Fu, Requirement for membrane lymphotoxin in natural killer cell development, Proc. Natl. Acad. Sci. U. S. A., 96: 6336–6340, 1999.
   PubMed Web of Science ®Google Scholar
• D. Elewaut, L. Brossay, S.M. Santee, O.V. Naidenko, N. Burdin, H. De Winter, J. Matsuda, C.F. Ware, H. Cheroutre, and M. Kronenberg, Membrane lymphotoxin is required for the development of different subpopulations of NK T cells, J. Immunol., 165: 671–679, 2000.
   PubMed Web of Science ®Google Scholar
• D. Elewaut, R.B. Shaikh, K.J. Hammond, H. De Winter, A.J. Leishman, S. Sidobre, O. Turovskaya, T.I. Prigozy, L. Ma, T.A. Banks, D. Lo, C.F. Ware, H. Cheroutre, and M. Kronenberg, NIK-dependent RelB activation defines a unique signaling pathway for the development of Vα14i NKT cells, J. Exp. Med., 197: 1623–1633, 2003.
   PubMedGoogle Scholar
• M. Schmidt-Supprian, J. Tian, E.P. Grant, M. Pasparakis, R. Maehr, H. Ovaa, H.L. Ploegh, A.J. Coyle, and K. Rajewsky, Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-κB activation, Proc. Natl. Acad. Sci. U. S. A., 101: 4566–4571, 2004.
   PubMed Web of Science ®Google Scholar
• Y. Kunisaki, Y. Tanaka, T. Sanui, A. Inayoshi, M. Noda, T. Nakayama, M. Harada, M. Taniguchi, T. Sasazuki, and Y. Fukui, DOCK2 is required in T cell precursors for development of Vα14 NK T cells, J. Immunol., 176: 4640–4645, 2006.
   Google Scholar
• P. Gadue, N. Morton, and P.L. Stein, The Src family tyrosine kinase Fyn regulates natural killer T cell development, J. Exp. Med., 190: 1189–1196, 1999.
   PubMed Web of Science ®Google Scholar
• G. Eberl, B. Lowin-Kropf, and H.R. MacDonald, Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice, J. Immunol., 163: 4091–4094, 1999.
   PubMed Web of Science ®Google Scholar
• B. Pasquier, L. Yin, M.C. Fondaneche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour, Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product, J. Exp. Med., 201: 695–701, 2005.
   PubMed Web of Science ®Google Scholar
• B. Chung, A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan, Cutting edge: Signaling lymphocytic activation molecule-associated protein controls NKT cell functions, J. Immunol., 174: 3153–3157, 2005.
   PubMed Web of Science ®Google Scholar
• K.E. Nichols, J. Hom, S.-Y. Gong, A. Ganguly, C.S. Ma, J.L. Cannons, S.G. Tangye, P.L. Schwartzberg, G.A. Koretzky, and P.L. Stein, Regulation of NKT cell development by SAP, the protein defective in XLP, Nat. Med., 11: 340–345, 2005.
   PubMed Web of Science ®Google Scholar
• K.E. Nichols, C.S. Ma, J.L. Cannons, P.L. Schwartzberg, and S.G. Tangye, Molecular and cellular pathogenesis of X-linked lymphoproliferative disease, Immunol. Rev., 203: 180–199, 2005.
   PubMed Web of Science ®Google Scholar
• A. Veillette, M.E. Cruz-Munoz, and M.C. Zhong, SLAM family receptors and SAP-related adaptors: Matters arising, Trends Immunol., 27: 228–234, 2006.
   Google Scholar
• D.B. Graham, M.P. Bell, M.M. McCausland, C.J. Huntoon, J. van Deursen, W.A. Faubion, S. Crotty, and D.J. McKean, Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice, J. Immunol., 176: 291–300, 2006.
   Google Scholar
• K. Benlagha, D.G. Wei, J. Veiga, L. Teyton, and A. Bendelac, Characterization of the early stages of thymic NKT cell development, J. Exp. Med., 202: 485–492, 2005.
   Google Scholar
• A. Bendelac, P. Matzinger, R.A. Seder, W.E. Paul, and R.H. Schwartz, Activation events during thymic selection, J. Exp. Med., 175: 731–742, 1992.
   PubMed Web of Science ®Google Scholar
• P. Gadue and P.L. Stein, NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation, J. Immunol., 169: 2397–2406, 2002.
   PubMed Web of Science ®Google Scholar
• S.P. Berzins, F.W. McNab, C.M. Jones, M.J. Smyth, and D.I. Godfrey, Long-term retention of mature NK1.1+ NKT cells in the thymus, J. Immunol., 176: 4059–4065, 2006.
   Google Scholar
• F.W. McNab, S.P. Berzins, D.G. Pellicci, K. Kyparissoudis, K. Field, M.J. Smyth, and D.I. Godfrey, The influence of CD1d in postselection NKT cell maturation and homeostasis, J. Immunol., 175: 3762–3768, 2005.
   Google Scholar
• J.L. Matsuda and L. Gapin, Developmental program of mouse V 14i NKT cells, Curr. Opin. Immunol., 17: 122–130, 2005.
   PubMed Web of Science ®Google Scholar
• T. Ranson, C.A. Vosshenrich, E. Corcuff, O. Richard, V. Laloux, A. Lehuen, and J.P. Di Santo, IL-15 availability conditions homeostasis of peripheral natural killer T cells, Proc. Natl. Acad. Sci. U. S. A., 100: 2663–2668, 2003.
   PubMed Web of Science ®Google Scholar
• M.J. Townsend, A.S. Weinmann, J.L. Matsuda, R. Salomon, P.J. Farnham, C.A. Biron, L. Gapin, and L.H. Glimcher, T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells, Immunity, 20: 477–494, 2004.
   PubMed Web of Science ®Google Scholar
• A.K. Stanic, J.S. Bezbradica, J.J. Park, N. Matsuki, A.L. Mora, L. Van Kaer, M.R. Boothby, and S. Joyce, NF-κB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes, J. Immunol., 172: 2265–2273, 2004.
   Google Scholar
• H.D. Lacorazza, Y. Miyazaki, A. Di Cristofano, A. Deblasio, C. Hedvat, J. Zhang, C. Cordon-Cardo, S. Mao, P.P. Pandolfi, and S.D. Nimer, The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells, Immunity, 17: 437–449, 2002.
   PubMed Web of Science ®Google Scholar
• K.L. Williams, A.J. Zullo, M.H. Kaplan, R.R. Brutkiewicz, C.D. Deppmann, C. Vinson, and E.J. Taparowsky, BATF transgenic mice reveal a role for activator protein-1 in NKT cell development, J. Immunol., 170: 2417–2426, 2003.
   Web of Science ®Google Scholar
• A. Hameg, C. Gouarin, J.M. Gombert, S. Hong, L. Van Kaer, J.F. Bach, and A. Herbelin, IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1−MHC class I-like/CD1-dependent CD4+ T cells, J. Immunol., 162: 7067–7074, 1999.
   Google Scholar
• A. Hameg, I. Apostolou, M. Leite-De-Moraes, J.M. Gombert, C. Garcia, Y. Koezuka, J.F. Bach, and A. Herbelin, A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the α-galactosylceramide antigen, J. Immunol., 165: 4917–4926, 2000.
   Google Scholar
• A.M. Moodycliffe, S. Maiti, and S.E. Ullrich, Splenic NK1.1−, TCR β intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN γ upon primary TCR stimulation, J. Immunol., 162: 5156–5163, 1999.
   Google Scholar
• S.Y. Thomas, R. Hou, J.E. Boyson, T.K. Means, C. Hess, D.P. Olson, J.L. Strominger, M.B. Brenner, J.E. Gumperz, S.B. Wilson, and A.D. Luster, CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells, J. Immunol., 171: 2571–2580, 2003.
   PubMed Web of Science ®Google Scholar
• B. Johnston, C.H. Kim, D. Soler, M. Emoto, and E.C. Butcher, Differential chemokine responses and homing patterns of murine TCR β NKT cell subsets, J. Immunol., 171: 2960–2969, 2003.
   Google Scholar
• M.K. Kennedy, M. Glaccum, S.N. Brown, E.A. Butz, J.L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C.R. Willis, K. Brasel, P.J. Morrissey, K. Stocking, J.C.L. Schuh, and J.J. Peshon, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice, J. Exp. Med., 191: 771–780, 2000.
   PubMed Web of Science ®Google Scholar
• J.P. Lodolce, D.L. Boone, S. Chai, R.E. Swain, T. Dassopoulos, S. Trettin, and A. Ma, IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation, Immunity, 9: 669–676, 1998.
   PubMed Web of Science ®Google Scholar
• O. Lantz, L.I. Sharara, F. Tilloy, A. Andersson, and J.P. DiSanto, Lineage relationships and differentiation of natural killer (NK) T cells: Intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules, J. Exp. Med., 185: 1395–1401, 1997.
   Google Scholar
• M. Stenstrom, M. Skold, A. Andersson, and S.L. Cardell, Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice, Immunology, 114: 336–345, 2005.
   Google Scholar
• K.J. Hammond, D.G. Pellicci, L.D. Poulton, O.V. Naidenko, A.A. Scalzo, A.G. Baxter, and D.I. Godfrey, CD1d-restricted NKT cells: An interstrain comparison, J. Immunol., 167: 1164–1173, 2001.
   PubMed Web of Science ®Google Scholar
• J. Yagi, U. Dianzani, H. Kato, T. Okamoto, T. Katsurada, D. Buonfiglio, T. Miyoshi-Akiyama, and T. Uchiyama, Identification of a new type of invariant Vα14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen, J. Immunol., 163: 3083–3091, 1999.
   Google Scholar
• A.K. Singh, J.Q. Yang, V.V. Parekh, J. Wei, C.R. Wang, S. Joyce, R.R. Singh, and L. Van Kaer, The natural killer T cell ligand alpha-galactosylceramide prevents or promotes pristane-induced lupus in mice, Eur. J. Immunol., 35: 1143–1154, 2005.
   PubMed Web of Science ®Google Scholar
• P.T. Lee, K. Benlagha, L. Teyton, and A. Bendelac, Distinct functional lineages of human Vα24 natural killer T cells, J. Exp. Med., 195: 637–641, 2002.
   PubMed Web of Science ®Google Scholar
• J.E. Gumperz, S. Miyake, T. Yamamura, and M.B. Brenner, Functionally distinct subsets of CDd-restricted NKT cells revealed by CD1d tetramer staining, J. Exp. Med., 195: 625–636, 2002.
   PubMed Web of Science ®Google Scholar
• Z.Y. Wang, S. Kusam, V. Munugalavadla, R. Kapur, R.R. Brutkiewicz, and A.L. Dent, Regulation of Th2 cytokine expression in NKT cells: Unconventional use of Stat6, GATA-3, and NFAT2, J. Immunol., 176: 880–888, 2006.
   Google Scholar
• N.Y. Crowe, J.M. Coquet, S.P. Berzins, K. Kyparissoudis, R. Keating, D.G. Pellicci, Y. Hayakawa, D.I. Godfrey, and M.J. Smyth, Differential antitumor immunity mediated by NKT cell subsets in vivo, J. Exp. Med., 202: 1279–1288, 2005.
   PubMed Web of Science ®Google Scholar
• M. Lisbonne, S. Diem, A. de Castro Keller, J. Lefort, L.M. Araujo, P. Hachem, J.M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, P. Van Endert, M. Dy, P. Askenase, M. Russo, B.B. Vargaftig, A. Herbelin, and M.C. Leite-de-Moraes, Cutting edge: Invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model, J. Immunol., 171: 1637–1641, 2003.
   PubMed Web of Science ®Google Scholar
• O. Akbari, P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M.J. Grusby, R.H. DeKruyff, and D.T. Umetsu, Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity, Nat. Med., 9: 582–588, 2003.
   PubMed Web of Science ®Google Scholar
• O. Akbari, J.L. Faul, E.G. Hoyte, G.J. Berry, J. Wahlstrom, M. Kronenberg, R.H. DeKruyff, and D.T. Umetsu, CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma, N. Engl. J. Med., 354: 1117–1129, 2006.
   PubMed Web of Science ®Google Scholar
• S.Y. Thomas, C.M. Lilly, and A.D. Luster, Invariant natural killer T cells in bronchial asthma, N. Engl. J. Med., 354: 2613–2616, author reply 2613–2616, 2006.
   PubMed Web of Science ®Google Scholar
• E.H. Meyer, S. Goya, O. Akbari, G.J. Berry, P.B. Savage, M. Kronenberg, T. Nakayama, R.H. DeKruyff, and D.T. Umetsu, Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells, Proc. Natl. Acad. Sci. U.S.A., 103: 2782–2787, 2006.
   PubMed Web of Science ®Google Scholar
• H. Matsuda, T. Suda, J. Sato, T. Nagata, Y. Koide, K. Chida, and H. Nakamura, αGalactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation, Am. J. Respir. Cell. Mol. Biol., 33: 22–31, 2005.
   PubMed Web of Science ®Google Scholar
• J.O. Kim, D.H. Kim, W.S. Chang, C. Hong, S.H. Park, S. Kim, and C.Y. Kang, Asthma is induced by intranasal coadministration of allergen and natural killer T-cell ligand in a mouse model, J. Allergy. Clin. Immunol., 114: 1332–1338, 2004.
   PubMed Web of Science ®Google Scholar
• S. Finotto, M.F. Neurath, J.N. Glickman, S. Qin, H.A. Lehr, F.H. Green, K. Ackerman, K. Haley, P.R. Galle, S.J. Szabo, J.M. Drazen, G.T. De Sanctis, and L.H. Glimcher, Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet, Science, 295: 336–338, 2002.
   PubMed Web of Science ®Google Scholar
• S. Finotto, M. Hausding, A. Doganci, J.H. Maxeiner, H.A. Lehr, C. Luft, P.R. Galle, and L.H. Glimcher, Asthmatic changes in mice lacking T-bet are mediated by IL-13, Int. Immunol., 17: 993–1007, 2005.
   PubMed Web of Science ®Google Scholar
• T. Kallinich, S. Schmidt, E. Hamelmann, A. Fischer, S. Qin, W. Luttmann, J.C. Virchow, and R.A. Kroczek, Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients, Clin. Exp. Allergy, 35: 26–33, 2005.
   Google Scholar
• Y. Sen, B. Yongyi, H. Yuling, X. Luokun, H. Li, X. Jie, D. Tao, Z. Gang, L. Junyan, H. Chunsong, X. Zhang, J. Youxin, G. Feili, J. Boquan, and T. Jinquan, Vα24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement, J. Immunol., 175: 4914–4926, 2005.
   PubMed Web of Science ®Google Scholar
• M.R. Sears, J.M. Greene, A.R. Willan, E.M. Wiecek, D.R. Taylor, E.M. Flannery, J.O. Cowan, G.P. Herbison, P.A. Silva, and R. Poulton, A longitudinal, population-based, cohort study of childhood asthma followed to adulthood, N. Engl. J. Med., 349: 1414–1422, 2003.
   PubMed Web of Science ®Google Scholar
• P. Pohunek, J.O. Warner, J. Turzikova, J. Kudrmann, and W.R. Roche, Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma, Pediatr. Allergy. Immunol., 16: 43–51, 2005.
   PubMed Web of Science ®Google Scholar
• E.W. Gelfand, A. Joetham, Z.H. Cui, A. Balhorn, K. Takeda, C. Taube, and A. Dakhama, Induction and maintenance of airway responsiveness to allergen challenge are determined at the age of initial sensitization, J. Immunol., 173: 1298–1306, 2004.
   PubMed Web of Science ®Google Scholar